Resmed (RSMDF) Free Cash Flow (2009 - 2026)

Resmed (RSMDF) has reported Free Cash Flow for 18 consecutive years, with $403.5 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Free Cash Flow fell 20.6% year-over-year to $403.5 million; the trailing twelve-month figure through Jun 2026 stood at $1.6 billion (down 0.73% YoY), and the FY2026 full-year result was $1.6 billion, down 0.73% from the prior year.
• Free Cash Flow eased to $403.5 million in Q2 2026 per RSMDF's latest filing, from $520.5 million in the prior quarter.
• Across five years, Free Cash Flow topped out at $557.9 million in Q1 2025 and bottomed at $15.6 million in Q3 2022.
• Historically, Free Cash Flow has averaged $294.8 million across 5 years, with a median of $297.8 million in 2024.
• The sharpest annual moves came in 2022 and 2023: Free Cash Flow sank 74.4% in 2022, then surged 1541.98% in 2023.
• Over 5 years, Free Cash Flow stood at $101.3 million in 2022, then surged by 146.31% to $249.5 million in 2023, then gained by 15.43% to $288.0 million in 2024, then rose by 8.07% to $311.2 million in 2025, then advanced by 29.66% to $403.5 million in 2026.
• According to Business Quant data, Free Cash Flow over the past three periods registered $403.5 million, $520.5 million, and $311.2 million for Q2 2026, Q1 2026, and Q4 2025 respectively.